Overview

Study of Olanzapine vs. Aripiprazole in the Treatment of Schizophrenia

Status:
Completed
Trial end date:
2007-07-01
Target enrollment:
Participant gender:
Summary
The purpose of the protocol is to evaluate the efficacy of olanzapine compared with Aripiprazole in patients with schizophrenia.
Phase:
Phase 4
Details
Lead Sponsor:
Eli Lilly and Company
Treatments:
Aripiprazole
Olanzapine